Myasthenia Gravis with Thymoma Complication: Dilemmas and Prospective Anesthesiology Approach

Pelinggo Jaya, Pratama Ananda, Novita Anggraeni

Abstract

Myasthenia gravis (MG) is an autoimmune disease affecting the postsynaptic neuromuscular junction. Myasthenia Gravis occurs in 1:7500 individuals, mostly female and or Asian. Myasthenia gravis can later be complicated with thymoma, and by several indications might need an operative approach. The need for thymectomy while there is a preexisting neuromuscular anomaly in Myasthenia gravis becomes a dilemma when choosing the right anesthetic regimens. This case report aims to discuss findings and offer a possible anesthetic approach that can be considered for cases of Myasthenia gravis with thymoma complications. We received a referred female patient with main complaints of dyspnoea, which was suspected as lung cancer. After further investigation, we found that the patient has previously been diagnosed with Myasthenia gravis, but did not follow through with her treatment plan. We performed a CT scan and confirmed a suspected thymoma as a complication of her Myasthenia gravis. Tymectomy was performed afterwards under general anesthesia. Post-operative extubation was successful, and maintenance of Myasthenia gravis treatment was followed by a neurologist. MG with thymoma is a rare finding in our hospital. Myasthenia gravis causes neurologic anomalies in which patients require special consideration on choosing a proper anesthesia regimen, as general anesthesia and muscle relaxants can worsen respiratory depression. Developing A proper scoring and suitable management plan will enhance the outcome and quality of life. Currently, there are several known anesthetic and supportive medicine approaches to thymectomy in Myasthenia gravis patients, including alternative regimens with similar efficacy.

Keywords

Anesthesia, Intubation, Myasthenia Gravis, Thymoma

References

Neuman A, Granlund B, Lansing MG. Anesthesia for patients with myasthenia gravis. NCBI StatPearls. 2024;1–6.

Suresh AB, Asuncion RMD. Myasthenia Gravis. NCBI StatPearls. 2023;1–10.

Lee HS, Lee HS, Shin HY, Choi Y, Kim SM. The epidemiology of myasthenia gravis in Korea. Yonsei Med J. 2016;57(2):419–25.

Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis : epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(2235):1–17.

Park SY, Lee JY, Lim NG, Hong YH. Incidence and Prevalence of myasthenia gravis in Korea : A Population-Based Study Using the National Health. Korean Neurol Assoc. 2016;12(3):340–4.

Octaviana F, Safri AY, Wiratman W, Indrawati LA, Fadli N, Hakim M. Pulmonary function assessment in myasthenia gravis patients in a National Referral Hospital in Indonesia. Int J Gen Med. 2023 Oct;16:4477–83.

Barreiro T, Perillo I. An Approach to interpreting spirometry. Am Fam Physician. 2004 Apr 1;69:1107–14.

Sari DP, Kurniawan SN. Myasthenia gravis. Journal of Pain, Headache and Vertigo [Internet]. 2023 Apr 4;4(1):16–9.

Mishra AK, Varma A. Myasthenia gravis : A Systematic review. Cureus. 2023;15(12):1–10.

Farmakidis C, Pasnoor M, Dimachkie MM, Richard J. Treatment of myasthenia gravis. Neuro Clin. 2019;36(2):311–37.

Alhaidar MK, Abumurad S, Soliven B, Rezania K. Current treatment of myasthenia gravis. J Clin Med. 2022;11(1597):1–23.

Zhang J, Chen Y, Chen J, Huang X, Wang H, Li Y, et al. AChRAb and MuSKAb double-seropositive myasthenia gravis : a distinct subtype ? Neurol Sci. 2021;42(58):863–9.

Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis : An Update. J Clin Med. 2021;10(1537):1–20.

Baldini, G. Dore, S. Finneran, J. Ilfeld, B. Anesthesia for patients with neuromuscular diseases. In: Morgan & Mikhail’s Clinical Anesthesiology. Editors: Butterworth JF, Mackey DC, Wasnick JD. 7th edition. New York: McGraw Hill; 2023. p. 1024-35

Charchaflieh, J G. Skin and collagn disorders in: stoelting’s anesthesia and co-existing disease. Editors: Hines RL, Jones SB. 8th Edition. Philadelphia: Elsevier; 2018. p. 509-12

Refbacks

  • There are currently no refbacks.